Geriatric Medicine Market

1
Geriatric Medicine Market
sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
2
Geriatric Medicine Market Global Scenario, Market
Size, Outlook, Trend, and Forecast, 2019 2028

• Global Geriatric Medicine Market size was
  estimated to be US 677.5 million in 2019 and is
  growing at a CAGR of 6.7 during 2021
  2028. Geriatric medicines, also called as
  geriatrics, is a branch of medicines related with
  preventive, healing, clinical and social parts of
  illness for the most part among individuals that
  are matured more than 65 years or more. Without
  appropriate consideration, a maturing body
  perpetually loses invulnerability and geriatrics
  are exceedingly inclined to neurological,
  cardiovascular, and respiratory sicknesses, among
  others. Geriatric drugs are a forte part of
  therapeutic science that gives modified
  diagnostics and treatment choices for the
  elderly, and the market for the equivalent is
  thriving.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
3
Geriatric Medicine Market Dynamics

• The primary factor attributing to the growth of
  the geriatric medicine market is a sudden rise in
  the elderly population across the globe, mainly
  in developed and emerging economies. In addition,
  the rising cases of chronic disorders such as
  cancers, diabetes, and arthritis among the
  geriatrics attributes for the growth of the
  market. The number of people over the age of 65
  increases from 9 in 2019 to more than 16 of
  the total worlds population by 2050. Thus, the
  increase in volume of the patient results in a
  higher demand for the market growth over the
  forecast period.
• North America dominates the global geriatric
  medicine market at present and the trend is
  expected to grow due to highly structured health
  care industry, growth of global market players,
  and high awareness of the latest therapeutic.
  Asia Pacific is expected to be a highly lucrative
  market for retinal disorders. 

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
4
High Incidence of Chronic Disease and Increase
Government Support for Elderly to Drive Market

• Increasing geriatric population along with
  increase in cases of chronic diseases is expected
  to propel the demand for geriatric medicines.
  High cases of unintended pregnancies is likely to
  drive the market. Stroke claims one fatality
  every 40 seconds in the U.S. and about 795,000
  people become victims of stroke (85 acute
  ischemic) every year and of which 610,000 of
  these are first or new strokes, and 185,000 are
  recurrent strokes.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
5
Analgesic Segment to Dominate Market

• The analgesic segment dominated the global
  geriatric medicine market in 2018. Increased need
  of painkillers for various chronic conditions,
  such as arthritis, is projected to boost the
  segment during the forecast period.
• Geriatric medicines market is segmented on the
  basis of indication, drug class, route of
  administration end-users and distribution
  channel. On the basis of indication, the global
  geriatric medicines market is segmented into
  cardiovascular, arthritis, diabetes,
  neurological, cancer, osteoporosis, respiratory
  and others. Based on drug class, the global
  geriatric medicines market is segmented into
  analgesic, antihypertensive, statins,
  antidiabetic, proton pump inhibitor,
  anticoagulant, antipsychotic, and antidepressant
  and others. Moreover, route of administration
  segment is categorized into oral, parenteral and
  others. By end-users, it is segmented into
  hospitals, home care, specialty clinics and
  others. Furthermore, on the basis of distribution
  channel, the global geriatric medicines market
  has been bifurcated into hospital pharmacy,
  online pharmacy and retail pharmacy.
• The prominent players covered in the global
  geriatric medicines market are Pfizer Inc, Otsuka
  Pharmaceutical Co., Ltd, AstraZeneca,
  Bristol-Myers Squibb Company, Allergan, Dr.
  Reddy's Laboratories Ltd, Pfizer Inc, Endo
  International plc, Teva Pharmaceutical Industries
  Ltd, Sun Pharmaceutical Industries Ltd, Mylan
  N.V., Novartis AG, Lupin, Cipla Inc, Aurobindo
  Pharma, Torrent Pharmaceuticals Ltd, Sanofi,
  Merck Co., Inc, Apotex Inc, Mayne Pharma Group
  Limited and others.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
6
Segmentation and Scope of Geriatric Medicine
Market

• The Geriatric Medicine Market is segmented as
  follows
• By Therapeutic Category
•  Analgesic
•  Antihypertensive
•  Statins
• Antidiabetic
• Proton Pump Inhibitor
• Anticoagulant
• Antipsychotic and Antidepressant
• By Condition
• Cardiovascular
•  Arthritis
•  Diabetes
•  Neurological
•  Cancer

• By End Users
•  Hospital Pharmacies
•  Retail Pharmacies
•  Online Pharmacies
•  
• By Geographical Region
• North America
• U.S.
• Canada
• Rest of North America
•  Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe

• o   Asia Pacific
•  China
•  India
•  Japan
•  Australia New Zealand
•  Rest of Asia Pacific
•  Latin America
• Brazil
• Mexico
• Rest of Latin America
•  Middle East Africa
• GCC Countries
• South Africa
• Rest of Africa
•   Rest of World (ROW)

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
7
 Competitive Landscape I key players

• The global geriatric medicine market is
  fragmented in terms of number of players. Key
  players in the global market include
• Pfizer Inc
• Merck Co Inc
• AstraZeneca
• Bristol-Myers Squibb Company
• Novartis AG
• Sanofi S.A.
• GlaxoSmithKline
• Cipla
• Aurobindo Pharma

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
8
Contact Us

• Accurize Market Research Pvt. Ltd.
• PATNA OFFICE K-129,
• PC COLONY,
• HANUMAN NAGAR,
• KANKARBAGH, PATNA, PIN-800020
• Emailhelp_at_accurizemarketresearch.com
• CONTACT NO1-339-368-6383

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research